Psoriasis.
D000287:Administration, Topical; D000875:Anthralin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D003631:Day Care, Medical; D003937:Diagnosis, Differential; D004643:Emollients / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D009260:Nail Diseases / Q000209:etiology; D011701:PUVA Therapy; D011379:Prognosis; D011565:Psoriasis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006435:Renal Dialysis; D013638:Tars / Q000627:therapeutic use; D014467:Ultraviolet Therapy; D014801:Vitamin A / Q000031:analogs & derivatives / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D004643:Emollients; D005938:Glucocorticoids; D007641:Keratolytic Agents; D013638:Tars; D014801:Vitamin A; D000875:Anthralin